Credit: Jovan Dragelj

In recent years, Jovan has shifted his focus towards biomedical research, studying topics such as cell divisome and COVID-19. In 2023, he moved into the biotech industry, joining HotSpot Therapeutics, where he currently works on computational drug discovery. In 2019, alongside a group of like-minded individuals, Jovan co-founded LGBTQ STEM Berlin. This initiative is dedicated to promoting visibility and representation of LGBTQ+ individuals in STEM fields (Science, Technology, Engineering, and Mathematics).

This interview was conducted by the editors of Communications Chemistry.